 | Up a level |
Hampel, B; Kusejko, K; Kouyos, R D; Böni, J; Flepp, M; Stöckle, M; Conen, A; Béguelin, C; Künzler-Heule, P; Nicca, D; Schmidt, A J; Nguyen, H; Delaloye, J; Rougemont, M; Bernasconi, E; Rauch, A; Günthard, H F; Braun, D L; Fehr, J (2020). Chemsex drugs on the rise: a longitudinal analysis of the Swiss HIV Cohort Study from 2007 to 2017. HIV medicine, 21(4), pp. 228-239. Wiley 10.1111/hiv.12821
Weber, R; Ruppik, M; Rickenbach, M; Spoerri, A; Furrer, Hansjakob; Battegay, M; Cavassini, M; Calmy, A; Bernasconi, E; Schmid, P; Flepp, M; Kowalska, J; Ledergerber, B; Swiss HIV Cohort Study, (SHCS) (2012). Decreasing mortality and changing patterns of causes of death in the Swiss HIV Cohort Study. HIV medicine, 14(4), pp. 195-207. Oxford: Blackwell Science 10.1111/j.1468-1293.2012.01051.x
Magenta, L; Dell-Kuster, S; Richter, W O; Young, J; Hasse, B; Flepp, M; Hirschel, B; Vernazza, P; Evison, J; Cavassini, M; Decosterd, L A; Bucher, H C; Bernasconi, E; Swiss HIV Cohort Study (SHCS), (2011). Lipid and lipoprotein profile in HIV-infected patients treated with lopinavir/ritonavir as a component of the first combination antiretroviral therapy. AIDS research and human retroviruses, 27(5), pp. 525-33. New York, N.Y.: Mary Ann Liebert 10.1089/aid.2010.0207
Bertschy, S; Opravil, M; Cavassini, M; Bernasconi, E; Schiffer, V; Schmid, P; Flepp, M; Chave, JP; Christen, A; Furrer, H; Swiss, HIV Cohort Study (2006). Discontinuation of maintenance therapy against toxoplasma encephalitis in AIDS patients with sustained response to anti-retroviral therapy. Clinical microbiology and infection, 12(7), pp. 666-71. Oxford: Blackwell Publishing 10.1111/j.1469-0691.2006.01459.x
Garlando, F; Rietiker, S; Täuber, MG; Flepp, M; Meier, B; Lüthy, R (1987). Single-dose ciprofloxacin at 100 versus 250 mg for treatment of uncomplicated urinary tract infections in women. Antimicrobial agents and chemotherapy, 31(2), pp. 354-6. Washington, D.C.: American Society for Microbiology 10.1128/AAC.31.2.354
Flepp, M; Täuber, MG (1986). [Opportunistic diseases in patients with HIV infection]. Praxis - schweizerische Rundschau für Medizin, 75(48), pp. 1445-50. Bern: Huber
Flepp, M; Täuber, MG; Lüthy, R; Frauchiger, B; Barandun, J; Schütze, M; Joller, H; Frey-Wettstein, M; Vetter, W; Siegenthaler, W (1986). [Transfusion-associated LAV/HTLV-III infections in Switzerland. Report of 2 cases]. Schweizerische medizinische Wochenschrift, 116(14), pp. 426-8. Basel: B. Schwabe & Co.
